In CRC, Bartolomé et al. found that silencing CDH17 reduced the levels of leucine-rich repeat-containing G-protein coupled receptor 5&6 (LGR5&6), which are stem cell markers that play key roles in Wnt activation. The gene discussed is LGR5; the disease is colorectal carcinoma.